Flow patterns regulate hyperglycemia-induced subendothelial matrix remodeling during early atherogenesis

Atherosclerosis

Volumn 232, Issue 2, 2014, Pages 277-284

  Green, Jonette ^a   Yurdagul, Arif ^a   McInnis, Marshall C ^a   Albert, Patrick ^a   Orr, A Wayne ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Atherosclerosis; Endothelial; Fibronectin; Hyperglycemia; Shear stress

Indexed keywords

FIBRONECTIN; GLUCOSE; THROMBOSPONDIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD FLOW; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

ATHEROSCLEROSIS; ENDOTHELIAL; FIBRONECTIN; HYPERGLYCEMIA; SHEAR STRESS;

ANIMALS; AORTA; AORTA, THORACIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BRACHIOCEPHALIC TRUNK; CAROTID ARTERIES; CELLS, CULTURED; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBRONECTINS; HUMANS; HYPERGLYCEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROCIRCULATION; REGIONAL BLOOD FLOW; THROMBOSPONDIN 1;

EID: 84892871832     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.11.052     Document Type: Article

References (43)

1. Fox C.S., Coady S., Sorlie P.D., et al. Trends in cardiovascular complications of diabetes. JAMA 2004, 292:2495-2499.
2. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. JAm Coll Cardiol 2009, 54:2129-2138.
3. Funk S.D., Yurdagul A., Orr A.W. Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med 2012, 2012. 569654.
4. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689.
5. Renard C.B., Kramer F., Johansson F., et al. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. JClin Invest 2004, 114:659-668.
6. McGill H.C., McMahan C.A., Zieske A.W., Malcom G.T., Tracy R.E., Strong J.P. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 2001, 103:1546-1550.
7. Jarvisalo M.J., Putto-Laurila A., Jartti L., et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 2002, 51:493-498.
8. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. NEngl J Med 2008, 358:2545-2559.
9. Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. NEngl J Med 2008, 358:2560-2572.
10. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. NEngl J Med 2008, 359:1577-1589.
11. Nathan D.M., Cleary P.A., Backlund J.Y., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. NEngl J Med 2005, 353:2643-2653.
12. Hahn C., Schwartz M.A. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 2009, 10:53-62.
13. Orr A.W., Sanders J.M., Bevard M., Coleman E., Sarembock I.J., Schwartz M.A. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. JCell Biol 2005, 169:191-202.
14. Funk S.D., Yurdagul A., Green J.M., Jhaveri K.A., Schwartz M.A., Orr A.W. Matrix-specific protein kinase A signaling regulates p21-activated kinase activation by flow in endothelial cells. Circ Res 2010, 106:1394-1403.
15. Orr A.W., Stockton R., Simmers M.B., Sanders J.M., Sarembock I.J., Blackman B.R., et al. Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis. JCell Biol 2007, 176:719-727.
16. Yurdagul A., Chen J., Funk S.D., Albert P., Kevil C.G., Orr A.W. Altered nitric oxide production mediates matrix-specific PAK2 and NF-kappaB activation by flow. Mol Biol Cell 2012.
17. Chiang H.Y., Korshunov V.A., Serour A., Shi F., Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol 2009, 29:1074-1079.
18. Rohwedder I., Montanez E., Beckmann K., et al. Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med 2012, 4:564-576.
19. Diez J. Arterial stiffness and extracellular matrix. Adv Cardiol 2007, 44:76-95.
20. Law B., Fowlkes V., Goldsmith J.G., Carver W., Goldsmith E.C. Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function. Microsc Microanal 2012, 18:22-34.
21. Roy S., Nasser S., Yee M., Graves D.T. Along-term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats. Mol Vis 2011, 17:3166-3174.
22. Roy S., Sato T., Paryani G., Kao R. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 2003, 52:1229-1234.
23. Kolset S.O., Reinholt F.P., Jenssen T. Diabetic nephropathy and extracellular matrix. JHistochem Cytochem 2012, 60:976-986.
24. Funk S.D., Yurdagul A., Albert P., et al. EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:686-695.
25. Orr A.W., Hahn C., Blackman B.R., Schwartz M.A. p21-activated kinase signaling regulates oxidant-dependent NF-kappa B activation by flow. Circ Res 2008, 103:671-679.
26. Orr A.W., Ginsberg M.H., Shattil S.J., Deckmyn H., Schwartz M.A. Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell 2006, 17:4686-4697.
27. Hallmann R., Horn N., Selg M., Wendler O., Pausch F., Sorokin L.M. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 2005, 85:979-1000.
28. Johnson J.L., Devel L., Czarny B., et al. Aselective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol 2011, 31:528-535.
29. Park L., Raman K.G., Lee K.J., et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 1998, 4:1025-1031.
30. Roy S., Ha J., Trudeau K., Beglova E. Vascular basement membrane thickening in diabetic retinopathy. Curr Eye Res 2010, 35:1045-1056.
31. Cherian S., Roy S., Pinheiro A. Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats. Invest Ophthalmol Vis Sci 2009, 50:943-949.
32. Tan M.H., Sun Z., Opitz S.L., Schmidt T.E., Peters J.H., George E.L. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 2004.
33. Roy S., Sala R., Cagliero E., Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A 1990, 87:404-408.
34. Ihnat M.A., Thorpe J.E., Kamat C.D., et al. Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia 2007, 50:1523-1531.
35. Vigorita V.J., Moore G.W., Hutchins G.M. Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset. Am J Cardiol 1980, 46:535-542.
36. Woo C.H., Shishido T., McClain C., et al. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circ Res 2008, 102:538-545.
37. Connell P., Walshe T., Ferguson G., Gao W., O'Brien C., Cahill P.A. Elevated glucose attenuates agonist- and flow-stimulated endothelial nitric oxide synthase activity in microvascular retinal endothelial cells. Endothelium 2007, 14:17-24.
38. Musicki B., Kramer M.F., Becker R.E., Burnett A.L. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A 2005, 102:11870-11875.
39. Jun J.Y., Ma Z., Segar L. Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis. Am J Physiol Endocrinol Metab 2011, 301:E145-154.
40. DeVerse J.S., Bailey K.A., Jackson K.N., Passerini A.G. Shear stress modulates RAGE-mediated inflammation in a model of diabetes-induced metabolic stress. Am J Physiol Heart Circ Physiol 2012, 302:H2498-2508.
41. Mohan S., Hamuro M., Koyoma K., Sorescu G.P., Jo H., Natarajan M. High glucose induced NF-kappaB DNA-binding activity in HAEC is maintained under low shear stress but inhibited under high shear stress: role of nitric oxide. Atherosclerosis 2003, 171:225-234.
42. Feaver R.E., Gelfand B.D., Wang C., Schwartz M.A., Blackman B.R. Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circ Res 2010, 106:1703-1711.
43. Gelfand B.D., Meller J., Pryor A.W., et al. Hemodynamic activation of beta-catenin and T-cell-specific transcription factor signaling in vascular endothelium regulates fibronectin expression. Arterioscler Thromb Vasc Biol 2011, 31:1625-1633.